These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 1695324

  • 1. Human trk oncogenes activated by point mutation, in-frame deletion, and duplication of the tyrosine kinase domain.
    Coulier F, Kumar R, Ernst M, Klein R, Martin-Zanca D, Barbacid M.
    Mol Cell Biol; 1990 Aug; 10(8):4202-10. PubMed ID: 1695324
    [Abstract] [Full Text] [Related]

  • 2. Molecular and biochemical characterization of the human trk proto-oncogene.
    Martin-Zanca D, Oskam R, Mitra G, Copeland T, Barbacid M.
    Mol Cell Biol; 1989 Jan; 9(1):24-33. PubMed ID: 2927393
    [Abstract] [Full Text] [Related]

  • 3. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
    Albor A, Thraves PJ, Dritschilo A, Notario V.
    Oncogene; 1996 Oct 17; 13(8):1755-63. PubMed ID: 8895522
    [Abstract] [Full Text] [Related]

  • 4. Mutational analysis of conserved residues in the tyrosine kinase domain of the human trk oncogene.
    Mitra G.
    Oncogene; 1991 Dec 17; 6(12):2237-41. PubMed ID: 1837350
    [Abstract] [Full Text] [Related]

  • 5. The trk family of oncogenes and neurotrophin receptors.
    Lamballe F, Klein R, Barbacid M.
    Princess Takamatsu Symp; 1991 Dec 17; 22():153-70. PubMed ID: 1844238
    [Abstract] [Full Text] [Related]

  • 6. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.
    Greco A, Pierotti MA, Bongarzone I, Pagliardini S, Lanzi C, Della Porta G.
    Oncogene; 1992 Feb 17; 7(2):237-42. PubMed ID: 1532241
    [Abstract] [Full Text] [Related]

  • 7. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.
    Greco A, Mariani C, Miranda C, Lupas A, Pagliardini S, Pomati M, Pierotti MA.
    Mol Cell Biol; 1995 Nov 17; 15(11):6118-27. PubMed ID: 7565764
    [Abstract] [Full Text] [Related]

  • 8. Frequent generation of oncogenes by in vitro recombination of TRK protooncogene sequences.
    Oskam R, Coulier F, Ernst M, Martin-Zanca D, Barbacid M.
    Proc Natl Acad Sci U S A; 1988 May 17; 85(9):2964-8. PubMed ID: 3362859
    [Abstract] [Full Text] [Related]

  • 9. Activation of the receptor kinase domain of the trk oncogene by recombination with two different cellular sequences.
    Kozma SC, Redmond SM, Fu XC, Saurer SM, Groner B, Hynes NE.
    EMBO J; 1988 Jan 17; 7(1):147-54. PubMed ID: 2966065
    [Abstract] [Full Text] [Related]

  • 10. Mechanism of activation of the human trk oncogene.
    Coulier F, Martin-Zanca D, Ernst M, Barbacid M.
    Mol Cell Biol; 1989 Jan 17; 9(1):15-23. PubMed ID: 2538716
    [Abstract] [Full Text] [Related]

  • 11. Oncogenic activation of the human trk proto-oncogene by recombination with the ribosomal large subunit protein L7a.
    Ziemiecki A, Müller RG, Fu XC, Hynes NE, Kozma S.
    EMBO J; 1990 Jan 17; 9(1):191-6. PubMed ID: 2403926
    [Abstract] [Full Text] [Related]

  • 12. Identification and biochemical characterization of p70TRK, product of the human TRK oncogene.
    Mitra G, Martin-Zanca D, Barbacid M.
    Proc Natl Acad Sci U S A; 1987 Oct 17; 84(19):6707-11. PubMed ID: 3477801
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes.
    Greco A, Miranda C, Pagliardini S, Fusetti L, Bongarzone I, Pierotti MA.
    Genes Chromosomes Cancer; 1997 Jun 17; 19(2):112-23. PubMed ID: 9172002
    [Abstract] [Full Text] [Related]

  • 15. Human TRK proto-oncogene maps to chromosome 1q32-q41.
    Miozzo M, Pierotti MA, Sozzi G, Radice P, Bongarzone I, Spurr NK, Della Porta G.
    Oncogene; 1990 Sep 17; 5(9):1411-4. PubMed ID: 2216464
    [Abstract] [Full Text] [Related]

  • 16. Activation of the proto-oncogene p60c-src by point mutations in the SH2 domain.
    O'Brien MC, Fukui Y, Hanafusa H.
    Mol Cell Biol; 1990 Jun 17; 10(6):2855-62. PubMed ID: 2111444
    [Abstract] [Full Text] [Related]

  • 17. Dissecting the activating mutations in v-erbB of avian erythroblastosis virus strain R.
    Shu HK, Pelley RJ, Kung HJ.
    J Virol; 1991 Nov 17; 65(11):6173-80. PubMed ID: 1681117
    [Abstract] [Full Text] [Related]

  • 18. Tissue-specific transformation by epidermal growth factor receptor: a single point mutation within the ATP-binding pocket of the erbB product increases its intrinsic kinase activity and activates its sarcomagenic potential.
    Shu HK, Pelley RJ, Kung HJ.
    Proc Natl Acad Sci U S A; 1990 Dec 17; 87(23):9103-7. PubMed ID: 1979168
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of activation of the vav protooncogene.
    Coppola J, Bryant S, Koda T, Conway D, Barbacid M.
    Cell Growth Differ; 1991 Feb 17; 2(2):95-105. PubMed ID: 2069873
    [Abstract] [Full Text] [Related]

  • 20. Molecular characterization of human trk proto-oncogene product monoclonal antibodies.
    Eager KB.
    Oncogene; 1991 May 17; 6(5):819-24. PubMed ID: 2052359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.